FOLD - Amicus Therapeutics EPS misses by $0.08 beats on revenue March, 01 2021 07:06 AM Amicus Therapeutics Inc. Amicus Therapeutics (FOLD): FY GAAP EPS of -$1.07 misses by $0.08.Revenue of $260.88M (+43.2% Y/Y) beats by $1.35M.Shares +0.16% PM.Press Release For further details see: Amicus Therapeutics EPS misses by $0.08, beats on revenue